Alpha Tau Medical Ltd. Statistics
Share Statistics
Alpha Tau Medical Ltd. has 69.92M shares outstanding. The number of shares has increased by 0.36% in one year.
| Shares Outstanding | 69.92M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 51.62M |
| Failed to Deliver (FTD) Shares | 63 |
| FTD / Avg. Volume | 0.13% |
Short Selling Information
The latest short interest is 67.06K, so 0.1% of the outstanding shares have been sold short.
| Short Interest | 67.06K |
| Short % of Shares Out | 0.1% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 3.01 |
Valuation Ratios
The PE ratio is -7.14 and the forward PE ratio is -4.61.
| PE Ratio | -7.14 |
| Forward PE | -4.61 |
| PS Ratio | 0 |
| Forward PS | 13.8 |
| PB Ratio | 2.46 |
| P/FCF Ratio | -8.54 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Alpha Tau Medical Ltd..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.07, with a Debt / Equity ratio of 0.16.
| Current Ratio | 12.07 |
| Quick Ratio | 12.08 |
| Debt / Equity | 0.16 |
| Total Debt / Capitalization | 13.58 |
| Cash Flow / Debt | -1.35 |
| Interest Coverage | 914.87 |
Financial Efficiency
Return on equity (ROE) is -0.35% and return on capital (ROIC) is 36.52%.
| Return on Equity (ROE) | -0.35% |
| Return on Assets (ROA) | -0.27% |
| Return on Capital (ROIC) | 36.52% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -240.97K |
| Employee Count | 121 |
| Asset Turnover | 0 |
| Inventory Turnover | -56.53 |
Taxes
| Income Tax | 16.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 27.56% in the last 52 weeks. The beta is 0.77, so Alpha Tau Medical Ltd.'s price volatility has been higher than the market average.
| Beta | 0.77 |
| 52-Week Price Change | 27.56% |
| 50-Day Moving Average | 2.83 |
| 200-Day Moving Average | 2.48 |
| Relative Strength Index (RSI) | 77.75 |
| Average Volume (20 Days) | 50.29K |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.07M |
| Operating Income | 35.68M |
| Net Income | -29.16M |
| EBITDA | -28.03M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.42 |
Balance Sheet
The company has 12.66M in cash and 13.28M in debt, giving a net cash position of -619.00K.
| Cash & Cash Equivalents | 12.66M |
| Total Debt | 13.28M |
| Net Cash | -619.00K |
| Retained Earnings | -115.76M |
| Total Assets | 90.73M |
| Working Capital | 63.44M |
Cash Flow
In the last 12 months, operating cash flow was -17.96M and capital expenditures -6.40M, giving a free cash flow of -24.36M.
| Operating Cash Flow | -17.96M |
| Capital Expenditures | -6.40M |
| Free Cash Flow | -24.36M |
| FCF Per Share | -0.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DRTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -10.55% |
| FCF Yield | -8.75% |
Analyst Forecast
The average price target for DRTS is $8, which is 101% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 101% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | 3.57 |
| Piotroski F-Score | 2 |